Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.4 USD | +1.36% | +3.24% | +3.45% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 51.05B |
---|---|---|---|---|---|
Net income 2024 * | 712M | Net income 2025 * | 896M | EV / Sales 2024 * | 12.1 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 1.02B | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
73.1
x | P/E ratio 2025 * |
59.2
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | +1.36% | ||
1 week | +3.24% | ||
Current month | +0.77% | ||
1 month | -7.32% | ||
3 months | +6.13% | ||
6 months | +31.72% | ||
Current year | +3.45% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 18 M€ | +3.01% | - | |
1.04% | 16 M€ | -4.51% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 128.4 | +1.36% | 1,778,982 |
24-05-02 | 126.6 | +0.61% | 2,311,410 |
24-05-01 | 125.9 | -1.19% | 2,916,511 |
24-04-30 | 127.4 | +1.26% | 3,049,287 |
24-04-29 | 125.8 | +1.18% | 3,846,764 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.45% | 51.05B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.66% | 26.59B | |
+3.21% | 26.78B | |
+15.23% | 25.86B | |
-0.03% | 25B |
- Stock Market
- Equities
- DXCM Stock